Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT03943693
Eligibility Criteria:
Inclusion Criteria:
* Outpatient or inpatients with atrial fibrillation sent for elective direct current cardioversion (DCCV) with at least 1 of the following risk factors will be included:
* BMI \>30
* History of Chronic Obstructive Pulmonary Disease/emphysema/asthma
* Significant Valvular heart disease (at least moderate regurgitation/stenosis)
* History of Heart Failure with preserved Ejection Fraction/Heart Failure with reduced Ejection Fraction
* Cardiomyopathy with ejection fraction \<40%
* Left atrium anterior-posterio (AP) dimension \>4.5cm
* Presence of Left ventricular hypertrophy (≥1.1cm septal/posterior wall M-mode) on transthoracic echocardiogram
* History of sleep apnea
Exclusion Criteria:
* Consent not obtained
* \<18 y.o.
* \>80 y.o.
* Not adequately anti-coagulated
* Patient hemodynamically unstable and DCCV required as an emergent procedure
* Prisoners or pregnant patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03943693
Study Brief:
Protocol Section:
NCT03943693